Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AMH
Valuation Weak
14%
Profitability n.A.
Fin. Growth Best
100%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 54.37 0.81 0.52
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -0.03 20.08 20.09
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.26 19.15 19.20
Cash 26.45 0.77 0.61
Capex 58.61 -0.09 -0.23
Free Cash Flow 260.98 0.46 0.13
Revenue 2.43 1.17 1.14
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -2.24 0.29 0.30
Operating Margin -4.27 0.22 0.23
ROA 39.98 < 0.005 < 0.005
ROE 39.79 0.02 0.01
ROIC -1.52 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AMH is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AMH is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AMH is permitted for members.